CAS 1269440-17-6 Safety Reference and Supplier SDS Request

Molecular weight

540 g/mol

Synonyms

Braftovi; LGX 818; Methyl N-[(2S)-1-({4-[3-(5-chloro-2-fluoro-3-methanesulfonamidophenyl)-1-(propan-2-yl)-1H-pyrazol-4-yl]pyrimidin-2-yl}amino)propan-2-yl]carbamate; encorafenibum; methyl N-((2S)-1-((4-(3-(5-chloro-2-fluoro-3-(methanesulfonamido)phenyl)-1-propan-2-ylpyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate; methyl N-((2S)-1-((4-(3-(5-chloro-2-fluoro-3-methanesulfonamidophenyl)-1-(propan-2-yl)-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate; Carbamic acid, N-[(1S)-2-[[4-[3-[5-chloro-2-fluoro-3-[(methylsulfonyl)amino]phenyl]-1-(1-methylethyl)-1H-pyrazol-4-yl]-2-pyrimidinyl]amino]-1-methylethyl]-, methyl ester; Encorafenib (LGX818); (S)-Methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate; (S)-Methyl [1-[[4-[3-[5-chloro-2-fluoro-3-(methylsulfonamido)phenyl]-1-isopropyl-1H-pyrazol-4-yl]pyrimidin-2-yl]amino]propan-2-yl]carbamate; methyl (S)-(1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate; Encorafenib [USAN:INN]

InChIKey

CMJCXYNUCSMDBY-ZDUSSCGKSA-N

PubChem CID

50922675